Met Life Investment Management, LLC Capricor Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $20.1 Billion
- Q3 2025
A detailed history of Met Life Investment Management, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 14,236 shares of CAPR stock, worth $80,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,236
Previous 22,242
35.99%
Holding current value
$80,148
Previous $220,000
53.18%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CAPR
# of Institutions
141Shares Held
13.3MCall Options Held
4MPut Options Held
2.76M-
Vanguard Group Inc Valley Forge, PA2.21MShares$12.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$9.17 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA962KShares$5.41 Million0.0% of portfolio
-
State Street Corp Boston, MA801KShares$4.51 Million0.0% of portfolio
-
Morgan Stanley New York, NY552KShares$3.11 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $137M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...